These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14450955)

  • 1. [The combination DBI-sulfonylurea derivative for diabetes mellitus].
    JAKOBSON T
    Nord Med; 1962 May; 67():585-9. PubMed ID: 14450955
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination of DBI with a sulfonylurea in diabetic therepy.
    JONCAS F
    Appl Ther; 1962 May; 4():476-9. PubMed ID: 14452210
    [No Abstract]   [Full Text] [Related]  

  • 3. [The results of testing in administration of a new sulfonylurea derivative (metzhexamide) in oral diabetes therapy].
    HUHN R; MAIBAUER D
    Arztl Forsch; 1960 May; 14():I/269-70. PubMed ID: 14403908
    [No Abstract]   [Full Text] [Related]  

  • 4. Critical appraisal of sulfonylurea therapy of diabetes mellitus.
    BEASER SB
    JAMA; 1960 Nov; 174():1233-6. PubMed ID: 13688250
    [No Abstract]   [Full Text] [Related]  

  • 5. [SULFONYLUREA SENSITIVITY: ITS SIGNIFICANCE IN THE THERAPY AND PROGNOSIS OF DIABETES MELLITUS].
    ANDREEV D
    Munch Med Wochenschr; 1964 Dec; 106():2259-62. PubMed ID: 14341467
    [No Abstract]   [Full Text] [Related]  

  • 6. [PROBLEMS OF LATE FAILURE OF ORAL SULFONYLUREA THERAPY OF DIABETES].
    STRAUZENBERG SE; HALLER H; MEYER H
    Schweiz Med Wochenschr; 1965 May; 95():628-36. PubMed ID: 14305109
    [No Abstract]   [Full Text] [Related]  

  • 7. [ORAL THERAPY OF DIABETES WITH SULFONYLUREA DERIVATIVES].
    OTTO H
    Medico (Eur); 1964; ():86-92. PubMed ID: 14171861
    [No Abstract]   [Full Text] [Related]  

  • 8. [Minimum insulin requirement and sulfonylurea therapy in diabetes mellitus].
    HOPKER W
    Klin Wochenschr; 1957 Jul; 35(13):668-72. PubMed ID: 13515033
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of orally administered biguanide and sulfonylurea with reference to a test for latent diabetes mellitus].
    GUTSCHE H
    Arzneimittelforschung; 1961 Dec; 11():1127-30. PubMed ID: 13903204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical indications and contraindications for peroral therapy of diabetics with sulfonylurea preparations].
    STRAUZENBERG SE; HALLER H
    Z Gesamte Inn Med; 1959 Jun; 14():529-33. PubMed ID: 13835158
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of diabetes mellitus with sulfonylureas].
    DELBUE C
    Dia Med; 1960 Apr; 32():752-6. PubMed ID: 13815618
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
    BOSHELL BR; WILENSKY AS; BARRETT JC; ALMON JV
    Clin Pharmacol Ther; 1962; 3():750-7. PubMed ID: 14014164
    [No Abstract]   [Full Text] [Related]  

  • 13. The long-term use of sulphonylureas in diabetes mellitus.
    STOWERS JM; BEWSHER PD
    Lancet; 1962 Jan; 1(7221):122-5. PubMed ID: 13917576
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL EVALUATION OF TOLCYCLAMIDE, A HYPOGLYCEMIC AGENT WITHOUT DEMONSTRABLE TOXICITY].
    VARGAS L; LIEBERMAN E; DOMENGE L; LOZANO O
    Rev Invest Clin; 1964; 16():449-62. PubMed ID: 14308569
    [No Abstract]   [Full Text] [Related]  

  • 15. [STUDIES ON THE PROBLEM OF THE SO-CALLED LATE FAILURE OF SULFONYLUREA THERAPY].
    MEHNERT H; REISNER E
    Dtsch Med Wochenschr; 1964 Jul; 89():1378-84. PubMed ID: 14160351
    [No Abstract]   [Full Text] [Related]  

  • 16. CYCLAMIDE (K-386) TREATMENT OF DIABETES MELLITUS.
    GRINCHENKO TS
    Fed Proc Transl Suppl; 1964; 23():767-8. PubMed ID: 14196927
    [No Abstract]   [Full Text] [Related]  

  • 17. ["Diabetic states" in pregnancy and their treatment with sulfonylurea derivatives. (Preliminary note)].
    LOPEZ-FERNANDIZ JR
    Hisp Med; 1960 Sep; 17():423-9. PubMed ID: 13763473
    [No Abstract]   [Full Text] [Related]  

  • 18. [POSSIBLE NON-DIABETIC EFFECTS OF SULFONYLUREA].
    BAUER G
    Medico (Eur); 1963; ():117-21. PubMed ID: 14065436
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term results in treatment of diabetes mellitus with the sulphonylureas.
    GORMAN CK; WEAVER JA
    Br Med J; 1959 Dec; 2(5161):1214-7. PubMed ID: 13851323
    [No Abstract]   [Full Text] [Related]  

  • 20. Metahexamide in diabetes therapy.
    MOSS JM; DELAWTER D
    Ann N Y Acad Sci; 1959 Sep; 82():614-7. PubMed ID: 14424617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.